Cover Image
Market Research Report
Product code 
1092248

IVD Raw Materials Market - Global Outlook & Forecast 2022-2027

Published: | Arizton Advisory & Intelligence | 342 Pages | Delivery time: 1-2 business days

Price

Back to Top
IVD Raw Materials Market - Global Outlook & Forecast 2022-2027
Published: June 20, 2022
Arizton Advisory & Intelligence
Content info: 342 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The IVD raw materials market by revenue is expected to grow at a CAGR of 5.86% during 2022-2027.

The following factors are likely to contribute to the growth of the IVD raw materials market during the forecast period:

  • Increasing Prevalence of Infectious & Chronic Diseases
  • Growing Awareness for Early Diagnosis and Disease Prevention
  • Surge In Demand for IVD Testing & Devices
  • Rise In Availability of Advanced Home Care Kits for Cancer Diagnostics

With the rise in chronic conditions and patient populations, the demand for diagnostics and laboratory tests increases. The growing demand for antigen and antibody-based tests that increased during COVID-19 led to its major market share.

The Europe region is one of the matured markets for in-vitro diagnostic; the large laboratory instruments are highly automated compared to most point-of-care testing devices. Automation has increased the speed and ease of using the devices the workforce is thoroughly trained and adopted. Furthermore, the global IVD raw materials market is expected to witness an incremental growth of USD 9.91 billion and absolute growth of 40.73% by 2027.

KEY HIGHLIGHTS

  • Growing trends for point of care diagnostics and personalized medicine contribute to the growth of the IVD raw materials market.
  • Investment in the development and commercial launch of IVD instruments and rapid test kits to diagnose several infectious diseases and their applications in the research segment will boost the market in developed countries.
  • In 2021, pharma & biotech companies accounted for the major share of 62.19% in the global IVD raw materials market. However, diagnostic laboratories are likely to witness the highest absolute growth of 43.37% during the forecast period.
  • Vendors offer a broad portfolio of quality enzymes that are highly suitable for manufacturing diagnostic kits and reagents. Manufacturers are also exploring new enzyme sources from enormous enzymes and optimizing and transforming the most appropriate enzyme molecules.

THIS RESEARCH REPORT INCLUDE A DETAILED SEGMENTATION ANALYSIS BY:

  • Product
  • Technology
  • End-User
  • Geography

SEGMENTATION ANALYSIS

Rapid tests developed through clinical chemistry provides test results immediately. Manufacturers offer many IVD raw materials applicable to clinical chemistry methods. The global IVD raw materials market by clinical chemistry is expected to reach USD 12.14 billion by 2027. Furthermore, private laboratories have expanded their footprints in recent years, especially in developing countries, which has stimulated market growth. Moreover, the demand for standalone reference laboratories is gradually rising due to the prevalence of epidemic and pandemic conditions across the globe. The global IVD raw materials market by diagnostic laboratories will grow at a CAGR of over 6% during 2022-2027.

  • Segmentation Analysis by Product
    • Antibody & Antigen
    • Enzymes
    • Proteins
    • Biological Buffers
    • Others
  • Segmentation Analysis by Technology
    • Clinical Chemistry
    • Immunochemistry
    • Molecular Diagnostics
    • Others
  • Segmentation Analysis by End-User
    • Pharma & Biotech Companies
    • Diagnostic Laboratories
    • Others

COMPETITIVE LANDSCAPE

Major manufacturers of IVD raw materials are focusing on their proprietary processing techniques that satisfy the raw material requirements of the IVD industry and provide IVD raw materials made to their own with the off-the-shelf specification. Vendors are constantly investing resources in R&D projects based on market trends and the demand for general health management. Key players are also engaged in strategic acquisitions as part of their inorganic growth strategy to enhance sales and profit margins. Strategic M&As continue to be an essential competitive strategy for key players to expand product offerings, access new technology, or increase market share. Vendors also focus on developing and commercializing innovative analyzers, COVID-19 PCR rapid test kits, and consumables to remain competitive and gain a significant presence in the IVD raw materials market.

Key Vendors

  • Aalto Bio Reagents
  • Fapon Biotech
  • Fujirebio
  • Merck KGaA
  • Hoffmann-La Roche
  • Thermo Fisher Scientific

Other Prominent Vendors

  • ABclonal
  • BBI Solutions
  • Beijing Diagreat Biotechnology
  • Biofootprints Healthcare
  • BioPorto
  • Creative Diagnostics
  • CUSABIO Technology
  • EUPROTEIN
  • Eximio Biotec
  • GenScript ProBio
  • Getein Biotech
  • Glentham Life Sciences
  • HyTest
  • ImmunoDiagnostics
  • LGC
  • Medix Biochemica
  • Meridian Bioscience
  • More Diagnostics
  • MP Biomedicals
  • Nanjing Okay Biotechnology
  • Nitto Boseki
  • OYC Europe
  • Prahas Healthcare
  • Promega
  • ReAgent
  • Rockland Immunochemicals
  • Sekisui Diagnostics
  • SERION Immunologics
  • Signalway Antibody
  • Suzhou Yacoo Science
  • Trina Bioreactives
  • Watson International
  • Wuhan Huamei Biotech

GEOGRAPHICAL ANALYSIS

In 2021, Europe dominated the global IVD raw materials market compared to other regions. This region is a mature market with developed diagnostic infrastructure available in most countries. The demand for advanced molecular diagnostics in the European countries has gone high owing to the presence of advanced infrastructure in healthcare diagnosis. Point of care diagnostics is the latest trend in the European market. The Europe IVD raw materials market is expected to reach USD 11.80 billion by 2027.

  • Geography
    • Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
    • North America
  • US
  • Canada
    • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
    • Latin America
  • Brazil
  • Mexico
  • Argentina
    • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa
Product Code: Sample_IVD Raw Materials Market - Global Outlook & Forecast 2022-2027_Arizton.pdf

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY PRODUCT
    • 4.3.2 MARKET SEGMENTATION BY TECHNOLOGY
    • 4.3.3 MARKET SEGMENTATION BY END USER
    • 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

  • 8.1 GROWING DEMAND FOR POINT-OF-CARE PCR DIAGNOSTICS
  • 8.2 SURGE IN PREFERENCE FOR PERSONALIZED MEDICINE
  • 8.3 RISE IN DEMAND FOR MOLECULAR DIAGNOSTICS
  • 8.4 ADVANCED TECHNOLOGIES IN IVD PRODUCTS

9 MARKET GROWTH ENABLERS

  • 9.1 INCREASING PREVALENCE OF INFECTIOUS & CHRONIC DISEASES
  • 9.2 GROWING AWARENESS OF EARLY DIAGNOSIS AND DISEASE PREVENTION
  • 9.3 HIGH DEMAND FOR IVD TESTS & DEVICES
  • 9.4 RISE IN AVAILABILITY OF ADVANCED HOME CARE KITS FOR CANCER DIAGNOSTICS

10 MARKET RESTRAINTS

  • 10.1 LOT-TO-LOT VARIATIONS IN IVD REAGENTS
  • 10.2 STRINGENT REGULATIONS FOR PRODUCT APPROVALS
  • 10.3 LOWER PENETRATION OF IVD DEVICES IN LMICS

11 MARKET LANDSCAPE

  • 11.1 MARKET OVERVIEW
  • 11.2 MARKET SIZE & FORECAST
    • 11.2.1 DEMAND FOR IVD RAW MATERIALS DURING COVID-19
  • 11.3 FIVE FORCES ANALYSIS
    • 11.3.1 THREAT OF NEW ENTRANTS
    • 11.3.2 BARGAINING POWER OF SUPPLIERS
    • 11.3.3 BARGAINING POWER OF BUYERS
    • 11.3.4 THREAT OF SUBSTITUTES
    • 11.3.5 COMPETITIVE RIVALRY

12 PRODUCT

  • 12.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 12.2 MARKET OVERVIEW
  • 12.3 ANTIBODIES & ANTIGENS
    • 12.3.1 MARKET OVERVIEW
    • 12.3.2 MARKET SIZE & FORECAST
    • 12.3.3 ANTIBODIES & ANTIGENS: GEOGRAPHY SEGMENTATION
  • 12.4 ENZYMES
    • 12.4.1 MARKET OVERVIEW
    • 12.4.2 MARKET SIZE & FORECAST
    • 12.4.3 ENZYMES: GEOGRAPHY SEGMENTATION
  • 12.5 PROTEINS
    • 12.5.1 MARKET OVERVIEW
    • 12.5.2 MARKET SIZE & FORECAST
    • 12.5.3 PROTEINS: GEOGRAPHY SEGMENTATION
  • 12.6 BIOLOGICAL BUFFERS
    • 12.6.1 MARKET OVERVIEW
    • 12.6.2 MARKET SIZE & FORECAST
    • 12.6.3 BIOLOGICAL BUFFERS: GEOGRAPHY SEGMENTATION
  • 12.7 OTHERS
    • 12.7.1 MARKET OVERVIEW
    • 12.7.2 MARKET SIZE & FORECAST
    • 12.7.3 OTHERS: GEOGRAPHY SEGMENTATION

13 TECHNOLOGY

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 CLINICAL CHEMISTRY
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 CLINICAL CHEMISTRY: GEOGRAPHY SEGMENTATION
  • 13.4 IMMUNOCHEMISTRY
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 IMMUNOCHEMISTRY: GEOGRAPHY SEGMENTATION
  • 13.5 MOLECULAR DIAGNOSTICS
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MOLECULAR DIAGNOSTICS: GEOGRAPHY SEGMENTATION
  • 13.6 OTHERS
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 OTHERS: GEOGRAPHY SEGMENTATION

14 END USER

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 PHARMA/BIOTECH & MEDTECH COMPANIES
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 PHARMA/BIOTECH & MEDTECH COMPANIES: GEOGRAPHY SEGMENTATION
  • 14.4 DIAGNOSTIC LABORATORIES
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION
  • 14.5 OTHERS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 OTHERS: GEOGRAPHY SEGMENTATION

15 GEOGRAPHY

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 GEOGRAPHIC OVERVIEW

16 EUROPE

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
    • 16.2.1 EUROPE: PRODUCT
    • 16.2.2 EUROPE: TECHNOLOGY
    • 16.2.3 EUROPE: END USER
  • 16.3 KEY COUNTRIES
    • 16.3.1 GERMANY: MARKET SIZE & FORECAST
    • 16.3.2 ITALY: MARKET SIZE & FORECAST
    • 16.3.3 FRANCE: MARKET SIZE & FORECAST
    • 16.3.4 UK: MARKET SIZE & FORECAST
    • 16.3.5 SPAIN: MARKET SIZE & FORECAST

17 NORTH AMERICA

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
    • 17.2.1 NORTH AMERICA: PRODUCT
    • 17.2.2 NORTH AMERICA: TECHNOLOGY
    • 17.2.3 NORTH AMERICA: END USER
  • 17.3 KEY COUNTRIES
    • 17.3.1 US: MARKET SIZE & FORECAST
    • 17.3.2 CANADA: MARKET SIZE & FORECAST

18 APAC

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 APAC: PRODUCT
    • 18.2.2 APAC: TECHNOLOGY
    • 18.2.3 APAC: END USER
  • 18.3 KEY COUNTRIES
    • 18.3.1 CHINA: MARKET SIZE & FORECAST
    • 18.3.2 JAPAN: MARKET SIZE & FORECAST
    • 18.3.3 INDIA: MARKET SIZE & FORECAST
    • 18.3.4 AUSTRALIA: MARKET SIZE & FORECAST
    • 18.3.5 SOUTH KOREA: MARKET SIZE & FORECAST

19 LATIN AMERICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 LATIN AMERICA: PRODUCT
    • 19.2.2 LATIN AMERICA: TECHNOLOGY
    • 19.2.3 LATIN AMERICA: END USER
  • 19.3 KEY COUNTRIES
    • 19.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 19.3.2 MEXICO: MARKET SIZE & FORECAST
    • 19.3.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 MIDDLE EAST & AFRICA: PRODUCT
    • 20.2.2 MIDDLE EAST & AFRICA: TECHNOLOGY
    • 20.2.3 MIDDLE EAST & AFRICA: END USER
  • 20.3 KEY COUNTRIES
    • 20.3.1 TURKEY: MARKET SIZE & FORECAST
    • 20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

  • 21.1 COMPETITION OVERVIEW
  • 21.2 MARKET SHARE ANALYSIS
    • 21.2.1 AALTO BIO REAGENTS
    • 21.2.2 FAPON BIOTECH
    • 21.2.3 FUJIREBIO
    • 21.2.4 MERCK KGAA
    • 21.2.5 F. HOFFMANN-LA ROCHE
    • 21.2.6 THERMO FISHER SCIENTIFIC

22 KEY COMPANY PROFILES

  • 22.1 AALTO BIO REAGENTS
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 AALTO BIO REAGENTS IN IVD RAW MATERIALS MARKET
    • 22.1.3 PRODUCT OFFERINGS
    • 22.1.4 KEY STRATEGIES
    • 22.1.5 KEY STRENGTHS
    • 22.1.6 KEY OPPORTUNITIES
  • 22.2 FAPON BIOTECH
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 FAPON BIOTECH IN IVD RAW MATERIALS MARKET
    • 22.2.3 PRODUCT OFFERINGS
    • 22.2.4 KEY STRATEGIES
    • 22.2.5 KEY STRENGTHS
    • 22.2.6 KEY OPPORTUNITIES
  • 22.3 FUJIREBIO
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 FUJIREBIO IN IVD RAW MATERIALS MARKET
    • 22.3.3 PRODUCT OFFERINGS
    • 22.3.4 KEY STRATEGIES
    • 22.3.5 KEY STRENGTHS
    • 22.3.6 KEY OPPORTUNITIES
  • 22.4 MERCK KGAA
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 MERCK KGAA IN IVD RAW MATERIALS MARKET
    • 22.4.3 PRODUCT OFFERINGS
    • 22.4.4 KEY STRATEGIES
    • 22.4.5 KEY STRENGTHS
    • 22.4.6 KEY OPPORTUNITIES
  • 22.5 F. HOFFMANN-LA ROCHE
    • 22.5.1 BUSINESS OVERVIEW
    • 22.5.2 F. HOFFMANN-LA ROCHE IN IVD RAW MATERIALS MARKET
    • 22.5.3 PRODUCT OFFERINGS
    • 22.5.4 KEY STRATEGIES
    • 22.5.5 KEY STRENGTHS
    • 22.5.6 KEY OPPORTUNITIES
  • 22.6 THERMO FISHER SCIENTIFIC
    • 22.6.1 BUSINESS OVERVIEW
    • 22.6.2 THERMO FISHER SCIENTIFIC IN IVD RAW MATERIALS MARKET
    • 22.6.3 PRODUCT OFFERINGS
    • 22.6.4 KEY STRATEGIES
    • 22.6.5 KEY STRENGTHS
    • 22.6.6 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

  • 23.1 ABCLONAL
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 PRODUCT OFFERINGS
  • 23.2 BBI SOLUTIONS
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 PRODUCT OFFERINGS
  • 23.3 BEIJING DIAGREAT BIOTECHNOLOGY
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 PRODUCT OFFERINGS
  • 23.4 BIOFOOTPRINTS HEALTHCARE
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 PRODUCT OFFERINGS
  • 23.5 BIOPORTO
    • 23.5.1 BUSINESS OVERVIEW
    • 23.5.2 PRODUCT OFFERINGS
  • 23.6 CREATIVE DIAGNOSTICS
    • 23.6.1 BUSINESS OVERVIEW
    • 23.6.2 PRODUCT OFFERINGS
  • 23.7 CUSABIO TECHNOLOGY
    • 23.7.1 BUSINESS OVERVIEW
    • 23.7.2 PRODUCT OFFERINGS
  • 23.8 EUPROTEIN
    • 23.8.1 BUSINESS OVERVIEW
    • 23.8.2 PRODUCT OFFERINGS
  • 23.9 EXIMIO BIOTEC
    • 23.9.1 BUSINESS OVERVIEW
    • 23.9.2 PRODUCT OFFERINGS
  • 23.10 GENSCRIPT PROBIO
    • 23.10.1 BUSINESS OVERVIEW
    • 23.10.2 PRODUCT OFFERINGS
  • 23.11 GETEIN BIOTECH
    • 23.11.1 BUSINESS OVERVIEW
    • 23.11.2 PRODUCT OFFERINGS
  • 23.12 GLENTHAM LIFE SCIENCES
    • 23.12.1 BUSINESS OVERVIEW
    • 23.12.2 PRODUCT OFFERINGS
  • 23.13 HYTEST
    • 23.13.1 BUSINESS OVERVIEW
    • 23.13.2 PRODUCT OFFERINGS
  • 23.14 IMMUNODIAGNOSTICS
    • 23.14.1 BUSINESS OVERVIEW
    • 23.14.2 PRODUCT OFFERINGS
  • 23.15 LGC
    • 23.15.1 BUSINESS OVERVIEW
    • 23.15.2 PRODUCT OFFERINGS
  • 23.16 MEDIX BIOCHEMICA
    • 23.16.1 BUSINESS OVERVIEW
    • 23.16.2 PRODUCT OFFERINGS
  • 23.17 MERIDIAN BIOSCIENCE
    • 23.17.1 BUSINESS OVERVIEW
    • 23.17.2 PRODUCT OFFERINGS
  • 23.18 MORE DIAGNOSTICS
    • 23.18.1 BUSINESS OVERVIEW
    • 23.18.2 PRODUCT OFFERINGS
  • 23.19 MP BIOMEDICALS
    • 23.19.1 BUSINESS OVERVIEW
    • 23.19.2 PRODUCT OFFERINGS
  • 23.20 NANJING OKAY BIOTECHNOLOGY
    • 23.20.1 BUSINESS OVERVIEW
    • 23.20.2 PRODUCT OFFERINGS
  • 23.21 NITTO BOSEKI
    • 23.21.1 BUSINESS OVERVIEW
    • 23.21.2 PRODUCT OFFERINGS
  • 23.22 OYC EUROPE
    • 23.22.1 BUSINESS OVERVIEW
    • 23.22.2 PRODUCT OFFERINGS
  • 23.23 PRAHAS HEALTHCARE
    • 23.23.1 BUSINESS OVERVIEW
    • 23.23.2 PRODUCT OFFERINGS
  • 23.24 PROMEGA
    • 23.24.1 BUSINESS OVERVIEW
    • 23.24.2 PRODUCT OFFERINGS
  • 23.25 REAGENT
    • 23.25.1 BUSINESS OVERVIEW
    • 23.25.2 PRODUCT OFFERINGS
  • 23.26 ROCKLAND IMMUNOCHEMICALS
    • 23.26.1 BUSINESS OVERVIEW
    • 23.26.2 PRODUCT OFFERINGS
  • 23.27 SEKISUI DIAGNOSTICS
    • 23.27.1 BUSINESS OVERVIEW
    • 23.27.2 PRODUCT OFFERINGS
  • 23.28 SERION IMMUNOLOGICS
    • 23.28.1 BUSINESS OVERVIEW
    • 23.28.2 PRODUCT OFFERINGS
  • 23.29 SIGNALWAY ANTIBODY
    • 23.29.1 BUSINESS OVERVIEW
    • 23.29.2 PRODUCT OFFERINGS
  • 23.30 SUZHOU YACOO SCIENCE
    • 23.30.1 BUSINESS OVERVIEW
    • 23.30.2 PRODUCT OFFERINGS
  • 23.31 TRINA BIOREACTIVES
    • 23.31.1 BUSINESS OVERVIEW
    • 23.31.2 PRODUCT OFFERINGS
  • 23.32 WATSON INTERNATIONAL
    • 23.32.1 BUSINESS OVERVIEW
    • 23.32.2 PRODUCT OFFERINGS
  • 23.33 WUHAN HUAMEI BIOTECH
    • 23.33.1 BUSINESS OVERVIEW
    • 23.33.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

  • 24.1 KEY TAKEAWAYS
  • 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

  • 25.1 MARKET BY PRODUCT
    • 25.1.1 EUROPE: PRODUCT SEGMENTATION
    • 25.1.2 NORTH AMERICA: PRODUCT SEGMENTATION
    • 25.1.3 APAC: PRODUCT SEGMENTATION
    • 25.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
    • 25.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
  • 25.2 MARKET BY TECHNOLOGY
    • 25.2.1 EUROPE: TECHNOLOGY SEGMENTATION
    • 25.2.2 NORTH AMERICA: TECHNOLOGY SEGMENTATION
    • 25.2.3 APAC: TECHNOLOGY SEGMENTATION
    • 25.2.4 LATIN AMERICA: TECHNOLOGY SEGMENTATION
    • 25.2.5 MIDDLE EAST & AFRICA: TECHNOLOGY SEGMENTATION
  • 25.3 MARKET BY END USER
    • 25.3.1 EUROPE: END USER SEGMENTATION
    • 25.3.2 NORTH AMERICA: END-USER SEGMENTATION
    • 25.3.3 APAC: END-USER SEGMENTATION
    • 25.3.4 LATIN AMERICA: END-USER SEGMENTATION
    • 25.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
  • 25.4 MARKET BY GEOGRAPHY
    • 25.4.1 ANTIBODIES & ANTIGENS: GEOGRAPHY SEGMENTATION
    • 25.4.2 ENZYMES: GEOGRAPHY SEGMENTATION
    • 25.4.3 PROTEINS: GEOGRAPHY SEGMENTATION
    • 25.4.4 BIOLOGICAL BUFFERS: GEOGRAPHY SEGMENTATION
    • 25.4.5 OTHER PRODUCTS: GEOGRAPHY SEGMENTATION
    • 25.4.6 CLINICAL CHEMISTRY: GEOGRAPHY SEGMENTATION
    • 25.4.7 IMMUNOCHEMISTRY: GEOGRAPHY SEGMENTATION
    • 25.4.8 MOLECULAR DIAGNOSTICS: GEOGRAPHY SEGMENTATION
    • 25.4.9 OTHER TECHNOLOGIES: GEOGRAPHY SEGMENTATION
    • 25.4.10 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION
    • 25.4.11 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION
    • 25.4.12 OTHER END USERS: GEOGRAPHY SEGMENTATION

26 APPENDIX

  • 26.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL IVD RAW MATERIALS MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 IMPACT OF GROWING DEMAND FOR POINT-OF-CARE PCR DIAGNOSTICS
  • EXHIBIT 4 IMPACT OF SURGE IN PREFERENCE FOR PERSONALIZED MEDICINE
  • EXHIBIT 5 IMPACT OF RISE IN DEMAND FOR MOLECULAR DIAGNOSTICS
  • EXHIBIT 6 IMPACT OF ADVANCED TECHNOLOGIES IN IVD PRODUCTS
  • EXHIBIT 7 IMPACT OF INCREASING PREVALENCE OF INFECTIOUS & CHRONIC DISEASES
  • EXHIBIT 8 IMPACT OF GROWING AWARENESS OF EARLY DIAGNOSIS AND DISEASE PREVENTION
  • EXHIBIT 9 MAJOR ADVANTAGES OF EARLY DIAGNOSIS AND DISEASE PREVENTION
  • EXHIBIT 10 IMPACT OF HIGH DEMAND FOR IVD TESTS & DEVICES
  • EXHIBIT 11 IMPACT OF RISE IN AVAILABILITY OF ADVANCED HOMECARE KITS FOR CANCER DIAGNOSTICS
  • EXHIBIT 12 IMPACT OF LOT-TO-LOT VARIATIONS IN IVD REAGENTS
  • EXHIBIT 13 IMPACT OF STRINGENT REGULATIONS FOR PRODUCT APPROVALS
  • EXHIBIT 14 IMPACT OF LOWER PENETRATION OF IVD DEVICES IN LMICS
  • EXHIBIT 15 GLOBAL IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 16 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT
  • EXHIBIT 17 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY
  • EXHIBIT 18 GLOBAL IVD RAW MATERIALS MARKET BY END USER
  • EXHIBIT 19 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY
  • EXHIBIT 20 WEEKLY MOLECULAR ASSAYS PERFORMED IN US AND EUROPE DURING NOVEMBER 2020 (MILLIONS)
  • EXHIBIT 21 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 22 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 23 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT
  • EXHIBIT 24 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT: INCREMENTAL GROWTH
  • EXHIBIT 25 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT: ABSOLUTE GROWTH
  • EXHIBIT 26 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 27 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021-2027 ($ BILLION)
  • EXHIBIT 28 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 29 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 30 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021-2027 ($ BILLION)
  • EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 32 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 33 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021-2027 ($ BILLION)
  • EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 35 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 36 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021-2027 ($ BILLION)
  • EXHIBIT 37 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 38 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 39 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021-2027 ($ BILLION)
  • EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 41 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 42 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY
  • EXHIBIT 43 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
  • EXHIBIT 44 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
  • EXHIBIT 45 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 46 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021-2027 ($ BILLION)
  • EXHIBIT 47 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 48 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 49 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021-2027 ($ BILLION)
  • EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 51 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 52 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021-2027 ($ BILLION)
  • EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 54 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 55 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021-2027 ($ BILLION)
  • EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 57 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 58 GLOBAL IVD RAW MATERIALS MARKET BY END USER
  • EXHIBIT 59 GLOBAL IVD RAW MATERIALS MARKET BY END USER: INCREMENTAL GROWTH
  • EXHIBIT 60 GLOBAL IVD RAW MATERIALS MARKET BY END USER: ABSOLUTE GROWTH
  • EXHIBIT 61 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 62 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 ($ BILLION)
  • EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 64 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 65 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021-2027 ($ BILLION)
  • EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 67 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 68 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021-2027 ($ BILLION)
  • EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 70 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 71 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY
  • EXHIBIT 72 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: KEY COUNTRIES (2021)
  • EXHIBIT 73 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
  • EXHIBIT 74 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
  • EXHIBIT 75 EUROPE IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 76 EUROPE IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 77 EUROPE IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 78 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 79 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 80 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 81 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 82 GERMANY IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 83 ITALY IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 84 FRANCE IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 85 UK IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 86 SPAIN IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 87 NORTH AMERICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 88 NORTH AMERICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 89 NORTH AMERICA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 90 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 91 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 92 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 93 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 94 US IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 95 CANADA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 96 APAC IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 97 APAC IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 98 APAC IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 99 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 100 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 101 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 102 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 103 CHINA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 104 JAPAN IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 105 INDIA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 106 AUSTRALIA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 107 SOUTH KOREA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 108 LATIN AMERICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 109 LATIN AMERICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 110 LATIN AMERICA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 111 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 112 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 113 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 114 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 115 BRAZIL IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 116 MEXICO IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 117 ARGENTINA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 118 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET: KEY COUNTRIES (2021)
  • EXHIBIT 119 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 120 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 121 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 122 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
  • EXHIBIT 123 INCREMENTAL GROWTH BY END USER 2021 & 2027
  • EXHIBIT 124 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 125 TURKEY IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 126 SAUDI ARABIA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 127 SOUTH AFRICA IVD RAW MATERIALS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 128 MERCK KGAA: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 129 MERCK KGAA: REVENUE BREAKDOWN BY SEGMENT 2018-2020 ($ MILLION)
  • EXHIBIT 130 MERCK KGAA: R&D EXPENDITURE 2018-2020 ($ MILLION)
  • EXHIBIT 131 MERCK KGAA: REVENUE BY GEOGRAPHIC REGION 2018-2020 ($ MILLION)
  • EXHIBIT 132 F. HOFFMANN-LA ROCHE: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 133 F. HOFFMANN-LA ROCHE: REVENUE BREAKDOWN BY DIVISION 2019-2021 ($ MILLION)
  • EXHIBIT 134 F. HOFFMANN-LA ROCHE: R&D EXPENDITURE 2019-2021 ($ MILLION)
  • EXHIBIT 135 F. HOFFMANN-LA ROCHE: REVENUE BY GEOGRAPHICAL REGION 2019-2021 ($ MILLION)
  • EXHIBIT 136 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2018-2020 ($ MILLION)
  • EXHIBIT 137 THERMO FISHER SCIENTIFIC: REVENUE BREAKDOWN BY SEGMENT 2018-2020 ($ MILLION)
  • EXHIBIT 138 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2018-2020 ($ MILLION)
  • EXHIBIT 139 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHICAL REGION 2018-2020 ($ MILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 LIST OF SOME IVD RAW MATERIALS APPLICABLE FOR DIFFERENT FUNCTIONS AND SYSTEMS
  • TABLE 4 VENDORS OFFERING ANTIBODIES & ANTIGENS AS IVD RAW MATERIALS
  • TABLE 5 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 6 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 7 VENDORS OFFERING ENZYMES AS IVD RAW MATERIALS
  • TABLE 8 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 9 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES 2021-2027 (%) (GEOGRAPHY)
  • TABLE 10 VENDORS OFFERING PROTEINS AS IVD RAW MATERIALS
  • TABLE 11 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 12 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 13 VENDORS OFFERING BIOLOGICAL BUFFERS AS IVD RAW MATERIALS
  • TABLE 14 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 15 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 16 VENDORS OFFERING HORMONES AS IVD RAW MATERIALS
  • TABLE 17 VENDORS OFFERING OTHER IVD RAW MATERIALS
  • TABLE 18 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 19 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 20 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 21 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021-2027 (%) (GEOGRAPHY)
  • TABLE 22 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 23 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021-2027 (%) (GEOGRAPHY)
  • TABLE 24 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 25 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 26 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 27 GLOBAL IVD RAW MATERIALS MARKET BY OTHERS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 28 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 29 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 (%) (GEOGRAPHY)
  • TABLE 30 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 31 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021-2027 (%) (GEOGRAPHY)
  • TABLE 32 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 33 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 34 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 35 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 36 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 37 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 38 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 39 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 40 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 41 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 42 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 43 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 44 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 45 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 46 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 47 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 48 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 49 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 50 APAC IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 51 APAC IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 52 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 53 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 54 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 55 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 56 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 57 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 58 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 59 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 60 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 61 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 62 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 63 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 64 AALTO BIO REAGENTS: MAJOR PRODUCT OFFERINGS
  • TABLE 65 FAPON BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 66 FUJIREBIO: MAJOR PRODUCT OFFERINGS
  • TABLE 67 MERCK KGAA: MAJOR PRODUCT OFFERINGS
  • TABLE 68 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
  • TABLE 69 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
  • TABLE 70 ABCLONAL: MAJOR PRODUCT OFFERINGS
  • TABLE 71 BBI SOLUTIONS: MAJOR PRODUCT OFFERINGS
  • TABLE 72 BEIJING DIAGREAT BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
  • TABLE 73 BIOFOOTPRINTS HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 74 BIOPORTO: MAJOR PRODUCT OFFERINGS
  • TABLE 75 CREATIVE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 76 CUSABIO TECHNOLOGY: MAJOR PRODUCT OFFERINGS
  • TABLE 77 EUPROTEIN: MAJOR PRODUCT OFFERINGS
  • TABLE 78 EXIMIO BIOTEC: MAJOR PRODUCT OFFERINGS
  • TABLE 79 GENSCRIPT PROBIO: MAJOR PRODUCT OFFERINGS
  • TABLE 80 GETEIN BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 81 GLENTHAM LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
  • TABLE 82 HYTEST: MAJOR PRODUCT OFFERINGS
  • TABLE 83 IMMUNODIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 84 LGC: MAJOR PRODUCT OFFERINGS
  • TABLE 85 MEDIX BIOCHEMICA: MAJOR PRODUCT OFFERINGS
  • TABLE 86 MERIDIAN BIOSCIENCE: MAJOR PRODUCT OFFERINGS
  • TABLE 87 MORE DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 88 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS
  • TABLE 89 NANJING OKAY BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
  • TABLE 90 NITTO BOSEKI: MAJOR PRODUCT OFFERINGS
  • TABLE 91 OYC EUROPE: MAJOR PRODUCT OFFERINGS
  • TABLE 92 PRAHAS HEALTHCARE: MAJOR PRODUCT OFFERINGS
  • TABLE 93 PROMEGA: MAJOR PRODUCT OFFERINGS
  • TABLE 94 REAGENT: MAJOR PRODUCT OFFERINGS
  • TABLE 95 ROCKLAND IMMUNOCHEMICALS: MAJOR PRODUCT OFFERINGS
  • TABLE 96 SEKISUI DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
  • TABLE 97 SERION IMMUNOLOGICS: MAJOR PRODUCT OFFERINGS
  • TABLE 98 SIGNALWAY ANTIBODY: MAJOR PRODUCT OFFERINGS
  • TABLE 99 SUZHOU YACOO SCIENCE: MAJOR PRODUCT OFFERINGS
  • TABLE 100 TRINA BIOREACTIVES: MAJOR PRODUCT OFFERINGS
  • TABLE 101 WATSON INTERNATIONAL: MAJOR PRODUCT OFFERINGS
  • TABLE 102 WUHAN HUAMEI BIOTECH: MAJOR PRODUCT OFFERINGS
  • TABLE 103 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 104 GLOBAL IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 105 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 106 EUROPE IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 107 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 108 NORTH AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 109 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 110 APAC IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 111 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 112 LATIN AMERICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 113 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 114 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 115 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 116 GLOBAL IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 117 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 118 EUROPE IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 119 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 120 NORTH AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 121 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 122 APAC IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 123 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 124 LATIN AMERICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 125 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 ($ BILLION)
  • TABLE 126 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY TECHNOLOGY 2021-2027 (%)
  • TABLE 127 GLOBAL IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 128 GLOBAL IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 129 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 130 EUROPE IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 131 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 132 NORTH AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 133 APAC IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 134 APAC IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 135 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 136 LATIN AMERICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 137 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 ($ BILLION)
  • TABLE 138 MIDDLE EAST & AFRICA IVD RAW MATERIALS MARKET BY END USER 2021-2027 (%)
  • TABLE 139 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY 2021-2027 ($ BILLION)
  • TABLE 140 GLOBAL IVD RAW MATERIALS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 141 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS BY GEOGRAPHY 2021-2027 ($ BILLION)
  • TABLE 142 GLOBAL IVD RAW MATERIALS MARKET BY ANTIBODIES & ANTIGENS BY GEOGRAPHY 2021-2027 (%)
  • TABLE 143 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES BY GEOGRAPHY 2021-2027 ($ BILLION)
  • TABLE 144 GLOBAL IVD RAW MATERIALS MARKET BY ENZYMES BY GEOGRAPHY 2021-2027 (%)
  • TABLE 145 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS BY GEOGRAPHY 2021-2027 ($ BILLION)
  • TABLE 146 GLOBAL IVD RAW MATERIALS MARKET BY PROTEINS BY GEOGRAPHY 2021-2027 (%)
  • TABLE 147 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS BY GEOGRAPHY 2021-2027 ($ BILLION)
  • TABLE 148 GLOBAL IVD RAW MATERIALS MARKET BY BIOLOGICAL BUFFERS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 149 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 150 GLOBAL IVD RAW MATERIALS MARKET BY OTHER PRODUCTS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 151 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 152 GLOBAL IVD RAW MATERIALS MARKET BY CLINICAL CHEMISTRY 2021-2027 (%) (GEOGRAPHY)
  • TABLE 153 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 154 GLOBAL IVD RAW MATERIALS MARKET BY IMMUNOCHEMISTRY 2021-2027 (%) (GEOGRAPHY)
  • TABLE 155 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 156 GLOBAL IVD RAW MATERIALS MARKET BY MOLECULAR DIAGNOSTICS 2021-2027 (%) (GEOGRAPHY)
  • TABLE 157 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 158 GLOBAL IVD RAW MATERIALS MARKET BY OTHER TECHNOLOGIES 2021-2027 (%) (GEOGRAPHY)
  • TABLE 159 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 160 GLOBAL IVD RAW MATERIALS MARKET BY PHARMA & BIOTECH COMPANIES 2021-2027 (%) (GEOGRAPHY)
  • TABLE 161 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 162 GLOBAL IVD RAW MATERIALS MARKET BY DIAGNOSTIC LABORATORIES 2021-2027 (%) (GEOGRAPHY)
  • TABLE 163 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021-2027 ($ BILLION) (GEOGRAPHY)
  • TABLE 164 GLOBAL IVD RAW MATERIALS MARKET BY OTHER END USERS 2021-2027 (%) (GEOGRAPHY)